Xiaflex Kit
NDC Package 66887-003-01
Package Information
Xiaflex (collagenase clostridium histolyticum) kits is a medication used to treat certain conditions (Dupuytren's contracture, Peyronie's disease) that are caused by a certain protein (collagen) in your body. This formulation utilizes a kit delivery system. Marketed by Endo Usa, Inc., this product is identified by NDC 66887-003 and is authorized under FDA application BLA125338.
Identification & Billing
- RxCUI: 898495 - collagenase Clostridium histolyticum 0.9 MG Injection
- RxCUI: 898499 - XIAFLEX 0.9 MG Injection
- RxCUI: 898499 - collagenase Clostridium histolyticum 0.9 MG Injection [Xiaflex]
- RxCUI: 898499 - Xiaflex 0.9 MG Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 66887 - Endo Usa, Inc.
- 66887-003 - Xiaflex
- 66887-003-01 - 1 KIT in 1 CARTON * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL * 3 mL in 1 VIAL
- 66887-003 - Xiaflex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (66887-003). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66887-003-01 identifies a specific commercial package of 1 kit in 1 carton * 1 injection, powder, lyophilized, for solution in 1 vial * 3 ml in 1 vial of Xiaflex, a human prescription drug labeled by Endo Usa, Inc.. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Endo Usa, Inc. on February 22, 2010. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat certain conditions (Dupuytren's contracture, Peyronie's disease) that are caused by a certain protein (collagen) in your body. Collagen is a tough and strong substance and is found in the knots/cords of the hand in Dupuytren's contracture or plaques in the penis in Peyronie's disease. Collagenase is a substance (enzyme) that breaks down the collagen in these knots/cords/plaques.
How is this Endo Usa, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66887000301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.